CAS 129300-27-2 is the registry number for Fabesetron, 95.72%. Offered by: MedChemExpress. Available pack sizes: Get quote.
Fabesetron is an organic heterotricyclic compound that is 8,9-dihydropyrido[1,2-a]indol-6(7H)-one substituted by a (5-methyl-1H-imidazol-4-yl)methyl group at position 7R and a methyl group at position 10. It is a dual 5-HT3 and 5-HT4 receptors antagonist whose clinical development was terminated in phase II. It was being developed for the treatment of chemotherapy-induced emesis and irritable bowel syndrome. It has a role as a serotonergic antagonist and an antiemetic. It is a member of imidazoles and an organic heterotricyclic compound.
Source: ChEBI
| Molecular formula | C18H19N3O |
|---|---|
| Molecular weight | 293.4 g/mol |
| IUPAC name | (7R)-10-methyl-7-[(5-methyl-1H-imidazol-4-yl)methyl]-8,9-dihydro-7H-pyrido[1,2-a]indol-6-one |
| InChIKey | AEKQMJRJRAHOAP-CYBMUJFWSA-N |
| SMILES | CC1=C2CC[C@@H](C(=O)N2C3=CC=CC=C13)CC4=C(NC=N4)C |
Computed by PubChem (NCBI)